Menu

Chris Fall Picked to Lead the Department of Energy’s Office of Science

Fall served in the White House Office of Science and Technology Policy under President Barack Obama.

May 21, 2018
Jim Daley

ISTOCK, MINGZHEZHANG

On Thursday (May 18), President Donald Trump announced that he intends to nominate Chris Fall to lead the Department of Energy’s Office of Science. The office has a $6-billion budget and is the primary funder of physical sciences research, according to Science. The position is currently vacant. Physicist Cherry Murray, who was appointed to the post by President Barack Obama, served from December 18, 2015 until January 13, 2017.  

Fall is currently the principal deputy director of the Department of Energy’s (DOE) Advanced Research Projects Agency-Energy (ARPA-E), which develops new research findings into commercial products. Before joining the DOE, he worked at the Office of Naval Research (ONR) for six years, where he oversaw studies of new technology for naval systems. Prior to that, he served for three years at the White House Office of Science and Technology Policy (OSTP) during President Obama’s administration. In that role, Fall was the assistant director for Defense Programs and later, the acting lead for the National Security and International Affairs Division.

Fall was a faculty member in the bioengineering and anatomy and cell biology departments at the University of Illinois at Chicago before joining the Obama administration. During his career in research, he investigated energy production in neurons and the link between cellular signaling systems and cellular energy production. He holds a PhD in neuroscience from the University of Virginia.

February 2019

Big Storms Brewing

Can forests weather more major hurricanes?

Marketplace

Sponsored Product Updates

Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Releases First FDA-Cleared Digital PCR System and Test for Monitoring Chronic Myeloid Leukemia Treatment Response
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, today announced that its QXDx AutoDG ddPCR System, which uses Bio-Rad’s Droplet Digital PCR technology, and the QXDx BCR-ABL %IS Kit are the industry’s first digital PCR products to receive U.S. Food and Drug Administration (FDA) clearance. Used together, Bio-Rad’s system and kit can precisely and reproducibly monitor molecular response to treatment in patients with chronic myeloid leukemia (CML).
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Showcases New Automation Features of its ZE5 Cell Analyzer at SLAS 2019
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) today showcases new automation features of its ZE5 Cell Analyzer during the Society for Laboratory Automation and Screening 2019 International Conference and Exhibition (SLAS) in Washington, D.C., February 2–6. These capabilities enable the ZE5 to be used for high-throughput flow cytometry in biomarker discovery and phenotypic screening.
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Andrew Alliance and Sartorius Collaborate to Provide Software-Connected Pipettes for Life Science Research
Researchers to benefit from an innovative software-connected pipetting system, bringing improved reproducibility and traceability of experiments to life-science laboratories.
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Life Sciences to Feature 3D Cell Culture Technologies at SLAS 2019
Corning Incorporated (NYSE: GLW) will showcase advanced 3D cell culture technologies and workflow solutions for spheroids, organoids, tissue models, and applications including ADME/toxicology at the Society for Laboratory Automation and Screening (SLAS) conference, Feb. 2-6 in Washington, D.C.